1. "Survivorship Research"
Formats
  1. Journal Article (8900)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15763)
  2. Department of Medicine (9202)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5184)
  5. Surgery (5131)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15763)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular profiling of immune activation associated with melanoma regression induced by diphencyprone
    Meeting Abstract

    Gulati, N.; Coit, D. G.; Fuentes-Duculan, J.; Gilleaudeau, P.; Sullivan-Whalen, M.; Suarez-Farinas, M.; Krueger, J. G.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Potential burden of germline findings in targeted tumor sequencing using matched normal DNA
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M. F.; Zehir, A.; Thomas, T.; Zhang, L. Y.; Ladanyi, M.; Offit, K.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Germline mutations in ETV6 confer risk of thrombocytopenia and acute lymphocytic leukemia
    Meeting Abstract

    Joseph, V.; Walsh, M. F.; Topka, S.; Wu, G.; McGee, R. B.; Quinn, E.; Inaba, H.; Hartford, C.; Pui, C. H.; Pappo, A. S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Functional genomics of HER2 and HER3 mutations and response to neratinib
    Meeting Abstract

    Hanrahan, A. J.; Hyman, D. M.; Sfakianos, J.; Jones, A.; Ramirez, R.; Johnsen, H.; Iyer, G.; Al-Ahmadie, H. A.; Bajorin, D.; Bochner, B. H.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Supplemental estrogen protects against obesity induced mammary gland inflammation in mice
    Meeting Abstract

    Bhardwaj, P.; Dui, B.; Zhou, X. K.; Sue, E.; Giri, D.; Harbus, M. D.; Falcone, D. J.; Hudis, C. A.; Subbaramaiah, K.; Dannenberg, A. J.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
    Meeting Abstract

    Desai, N. B.; Iyer, G.; Cha, E. K.; Scott, S. N.; Hreiki, J.; Sfakianos, J. P.; Kim, P.; Bagroida, A.; Bochner, B. H.; Rosenberg, J. E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • The finding of Del 17p in marrow plasma cells from patients with light-chain amyloidosis (AL) may confer a worse prognosis
    Meeting Abstract

    Wong, S. W.; Palladini, G.; Hegenbart, U.; Landau, H.; Warner, M.; Jaccard, A.; Avet-Loiseau, H.; Hansen, T.; Blade, J.; Cibeira, M. T.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Impact of busulphan exposure on transplant outcomes for patients with advanced myelodysplastic syndromes undergoing CD34 selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Tamari, R.; Proli, A.; Zheng, J. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Devlin, S.; Sauter, C. S.; Young, J. W.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma
    Meeting Abstract

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
    Blood (2015)

    Fulltext@MSK | Save